Financial Performance - Net loss attributable to common shareholders was $(116395) thousand for the six months ended June 30, 2025[111] - Funds From Operations (FFO) was $50775 thousand for the six months ended June 30, 2025, or $015 per diluted share for Q2 2025[121] - Cash Available for Distribution (CAD) was $30546 thousand for the six months ended June 30, 2025, with a CAD payout ratio of 1726%[123] - Same Store NOI increased by 10% GAAP and 63% Cash for Q2 2025[12] Leasing and Occupancy - Wholly-owned portfolio occupancy was 886% at the end of Q2 2025, and 911% leased as of July 18, 2025[9] - Total leases executed in the wholly-owned portfolio during Q2 2025 were 233844 square feet[7] - Tenant retention for the core portfolio was 819% in Q2 2025[12] Development and Dispositions - The company recognized aggregate impairment charges of $341 million due to rezoning permit application for residential conversion of two properties within Austin segment[6] - Completed the sale of a wholly-owned office property in Austin, Texas for a gross sales price of $176 million[8] - Construction started on a 120-room luxury boutique hotel in Radnor, Pennsylvania, estimated to cost $595 million[8] Capital Structure - Issued $1500 million of 8875% guaranteed notes due 2029 for net proceeds of $1575 million[8] - Repaid construction loan of $436 million related to 155 King of Prussia Road with cash on-hand[8] - Net debt to total gross assets was 490% as of June 30, 2025[12]

Financial Performance - Net income available to common stockholders for the second quarter of 2025 was $563 million[17], compared to $394 million in 2Q24[27], an increase of 25%[18] - Year-to-date net income available to common stockholders reached $1112 million[16], a 28% increase compared to $869 million in the same period of 2024[28] - The company's Return on Average Assets (ROAA) for the second quarter was 123%[15], and year-to-date ROAA was 122%[12] - The Return on Tangible Common Equity (ROTCE) was 1449% for the second quarter[17], and 1430% year-to-date[12] - The efficiency ratio for the second quarter was 5399%[17], and 5426% year-to-date[18] Loan and Deposit Growth - Total loans reached $133 billion[12], with a quarterly growth of $2976 million, or 91% annualized[17], and year-to-date growth of $4525 million, or 70% annualized[18] - Commercial loans experienced strong growth during the quarter of approximately $262 million, or 107%[23], and year-to-date growth of approximately $431 million, or 89%[23] - Total deposits amounted to $148 billion[12], with a quarterly increase of $3356 million, or 93% annualized[27], and year-to-date growth of $2285 million, or 38%[28] - Commercial deposits increased by approximately $347 million during the quarter[25], while consumer deposits declined by approximately $108 million[25] Capital Management - The company repurchased 582486 shares totaling $221 million during the second quarter[15] - Year-to-date, the company repurchased 818480 shares totaling $317 million[18] - The tangible common equity ratio stood at 892%[12]

FTI Consulting, Inc. Second Quarter 2025 Earnings Conference Call July 24, 2025 Cautionary Note About Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve uncertainties and risks. Forward-looking statements include statements concerning our plans, initiatives, projections, prospects, policies, processes and practices, obje ...

Ensuring our Clients and Our Institution Succeed Boldly Esquire Financial Holdings, Inc. (Financial Holding Company for Esquire Bank, N.A.) 2Q 2025 Investor Presentation Listed as ESQ Forward Looking Disclosure This presentation contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements are not historical fact and express management's current expectations, forecasts of future events or long-term goals and, by their nature, are subject to assumptions, ri ...

Financial Performance - Total Net Sales increased by 1.8% to $1,481.5 million in Q2 2025 compared to $1,455.3 million in Q2 2024[4] - Gross Margin increased by 5.8% to $345.9 million in Q2 2025 compared to $326.9 million in Q2 2024[4] - Net Income decreased significantly by 83.9% to $12.7 million in Q2 2025 compared to $78.9 million in Q2 2024[4] - EPS Diluted decreased by 83.7% to $0.08 in Q2 2025 compared to $0.49 in Q2 2024[4] - Total combined adjusted EBITDA decreased by 8.8% to $249.5 million in Q2 2025 compared to $273.6 million in Q2 2024[4] Segment Performance - Feed segment adjusted EBITDA increased by 11.3% to $135.9 million in Q2 2025 compared to $122.1 million in Q2 2024[4] - Food segment adjusted EBITDA decreased by 4.5% to $69.9 million in Q2 2025 compared to $73.2 million in Q2 2024[4] - Fuel segment adjusted EBITDA decreased by 29.1% to $61.3 million in Q2 2025 compared to $96.8 million in Q2 2024[4] Balance Sheet - Cash and cash equivalents were $95 million as of June 28, 2025, compared to $76 million as of December 28, 2024[5] - Total debt was $3,980 million as of June 28, 2025, compared to $4,042 million as of December 28, 2024[5]

Visteon Q2 2025 Earnings July 24, 2025 Q2 2025 in Review Another quarter of strong financial results and progress towards our long-term goals $969 Million Net Sales $134 Million Adjusted EBITDA $67 Million Adjusted FCF (1%) Growth-over-Market* 13.8% Margin $361 Million Net Cash Reinstating and raising full-year financial guidance and initiating quarterly dividend BALANCE SHEET ENABLES FLEXIBLE CAPITAL ALLOCATION CONTINUED OPERATIONAL DISCIPLINE Launched 21 new products and expanded margins STRATEGIC INITIAT ...

Financial Performance - Q2 2025 - Total Adjusted EBITDA for Q2 2025 was $627.8 million[6], compared to $574.6 million in Q2 2024[6], an increase - The company's Q2 2025 revenue, as reported, reached $3.5273 billion[21], a 9.5% increase year-over-year from $3.2209 billion in Q2 2024[21] - Adjusted earnings per share for Q2 2025 was $4.35[23], compared to $3.94 in Q2 2024[23] Revenue Breakdown and Growth - Enterprise revenue, as reported, for Q2 2025 was $3.527 billion[8], reflecting a 9.5% year-over-year growth[8] - Diagnostics Laboratories revenue, as reported, for Q2 2025 was $2.749 billion[8], showing an 8.9% year-over-year growth[8] - Biopharma Laboratory Services revenue, as reported, for Q2 2025 was $785 million[8], a significant 11% increase year-over-year[8] Outlook for 2025 - The company projects full-year 2025 revenue for Labcorp Enterprise to be between $13.98 billion and $14.13 billion[18], representing a 7.5% to 8.6% increase versus 2024 results[18] - The company anticipates adjusted EPS for 2025 to be in the range of $16.05 to $16.50[18], a 10.1% to 13.2% increase compared to 2024[18] Biopharma Laboratory Services Metrics - The Trailing Twelve Month (TTM) Net Orders ending June 30, 2025, for Biopharma Laboratory Services reached $3.34 billion[17], with a Net Book-to-Bill ratio of 1.11x[17] - As of June 30, 2025, the backlog for Biopharma Laboratory Services was $8.71 billion[17], with an estimated $2.71 billion expected to convert to revenue in the next twelve months[17]

NYSE:BHLB Berkshire Hills Bancorp 2Q 2025 Earnings Presentation NON-GAAP FINANCIAL MEASURES This presentation contains both financial measures based on accounting principles generally accepted in the United States ("GAAP") and non-GAAP based financial measures, which are used where management believes them to be helpful in understanding the Company's results of operations or financial position. Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures are included in the appe ...

Financial Performance - The company's reported diluted EPS was $038[6] - The company's reported Return on Average Assets was 090%[6] - The company's reported Return on Average Tangible Common Equity was 1093%[6] - The company's efficiency ratio was 526%[6] - Nonperforming assets to total assets was 019%[6] Net Interest Margin and Income - Net interest margin (NIM) increased by 11 bps from 1Q25 to 262%, while core NIM increased by 12 bps to 249%[6] - Net interest income increased by $22 million, or 74%, from 1Q25[6] Balance Sheet Growth - Loan balances increased by $126 million, or 125% annualized, from 1Q25[6] - Total deposit balances increased by $74 million, or 72% annualized, from 1Q25, with core deposit balances increasing by $16 million, or 21% annualized[6] Capital and Shareholder Value - Tangible book value per share increased by 92% annualized from 1Q25 to $1421[6] - The company repurchased 122,704 shares of common stock at an aggregate purchase price of $16 million, with an average price of $1280 per share[6]

Financial Performance - Ardagh Metal Packaging (AMP) reported strong Q2 2025 results, outperforming guidance, and raised the full-year Adjusted EBITDA guidance to $705-$725 million[14] - Q2 2025 global shipments grew by 5%[15] - Q2 2025 Adjusted EBITDA reached $210 million, exceeding the guidance range of $195-$205 million[16] - Group revenue in Q2 2025 was $1455 million, a 16% increase compared to $1259 million in Q2 2024[32] - Adjusted EBITDA increased by 18% to $210 million in Q2 2025, compared to $178 million in Q2 2024[31] Regional Performance - Americas experienced strong growth in Q2 2025, with Adjusted EBITDA increasing by 34%[16] - North America saw an 8% growth in Q2 2025, driven by non-alcoholic beverages[16] - Brazil's growth was 12% in Q2 2025, reflecting customer mix[16] - Europe experienced a 1% growth in Q2 2025, with strength in soft drinks offset by market weakness in beer[16] Market Trends and Strategy - Beverage cans are gaining share in the packaging mix across regions[23] - AMP anticipates minimal impact from tariffs due to the regional nature of its supply chain[16] - The company maintains a disciplined approach to capital deployment, focusing on network optimization and flexibility[38]